Objective: To report a case of decreased international normalized ratio (INR) in a patient receiving warfarin and bosentan.
Case Summary: A 35-year-old African American woman with a history of primary pulmonary hypertension managed with warfarin, diltiazem, and hydrochlorothiazide was initiated on bosentan therapy. The patient's INR had been stable and within therapeutic range (goal 2.